Rachel Freeman

1.2k total citations
23 papers, 332 citations indexed

About

Rachel Freeman is a scholar working on Applied Microbiology and Biotechnology, Epidemiology and Molecular Medicine. According to data from OpenAlex, Rachel Freeman has authored 23 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Applied Microbiology and Biotechnology, 8 papers in Epidemiology and 7 papers in Molecular Medicine. Recurrent topics in Rachel Freeman's work include Antibiotic Use and Resistance (11 papers), Antibiotic Resistance in Bacteria (7 papers) and Bacterial Identification and Susceptibility Testing (5 papers). Rachel Freeman is often cited by papers focused on Antibiotic Use and Resistance (11 papers), Antibiotic Resistance in Bacteria (7 papers) and Bacterial Identification and Susceptibility Testing (5 papers). Rachel Freeman collaborates with scholars based in United Kingdom, Uganda and United States. Rachel Freeman's co-authors include Alison Holmes, André Charlett, Luke Moore, Leticia García-Álvarez, Hugo Donaldson, Berit Müller‐Pebody, Julie V. Robotham, Koen B. Pouwels, Katherine L. Henderson and Timo Smieszek and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, BMC Medicine and Journal of Pain and Symptom Management.

In The Last Decade

Rachel Freeman

22 papers receiving 327 citations

Peers

Rachel Freeman
Derek N. Bremmer United States
Ryan W. Stevens United States
Sean Nguyen United States
Ella Ebadi Germany
Carlos Palos Portugal
Emmanuel Wey United Kingdom
Kristi Kuper United States
Domenica Flury Switzerland
Derek N. Bremmer United States
Rachel Freeman
Citations per year, relative to Rachel Freeman Rachel Freeman (= 1×) peers Derek N. Bremmer

Countries citing papers authored by Rachel Freeman

Since Specialization
Citations

This map shows the geographic impact of Rachel Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Freeman more than expected).

Fields of papers citing papers by Rachel Freeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Freeman. The network helps show where Rachel Freeman may publish in the future.

Co-authorship network of co-authors of Rachel Freeman

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Freeman. A scholar is included among the top collaborators of Rachel Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Freeman. Rachel Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Moore, Luke, et al.. (2024). Antimicrobial stewardship markers and healthcare-associated pneumonia threshold criteria in UK hospitals: analysis of the MicroGuideTm application. JAC-Antimicrobial Resistance. 6(2). dlae058–dlae058. 1 indexed citations
3.
Freeman, Rachel, Adam Doble, Gillian Hood, et al.. (2023). Appropriateness of acute-care antibiotic prescriptions for community-acquired infections and surgical antibiotic prophylaxis in England: analysis of 2016 national point prevalence survey data. Journal of Hospital Infection. 142. 115–129. 5 indexed citations
4.
Pople, Diane, Theodore Kypraios, Tjibbe Donker, et al.. (2023). Model-based evaluation of admission screening strategies for the detection and control of carbapenemase-producing Enterobacterales in the English hospital setting. BMC Medicine. 21(1). 492–492. 2 indexed citations
5.
Namisango, Eve, Richard A. Powell, Steve L. Taylor, et al.. (2022). Depressive Symptoms and Palliative Care Concerns Among Patients With Non-communicable Diseases in Two Southern African Countries. Journal of Pain and Symptom Management. 65(1). 26–37. 5 indexed citations
7.
Freeman, Rachel, et al.. (2021). Hepatitis E in Namibia: A Historical Review. African Journal of Health Sciences. 34(4). 422–436. 1 indexed citations
8.
Freeman, Rachel, et al.. (2020). Lasting lessons learnt in the radiology department from the battle with COVID-19. Clinical Radiology. 75(8). 586–591. 8 indexed citations
9.
Freeman, Rachel, Dean Ironmonger, Katie L. Hopkins, et al.. (2020). Epidemiology of carbapenemase-producing Enterobacterales in England, May 2015–March 2019: national enhanced surveillance findings and approach. Infection Prevention in Practice. 2(3). 100051–100051. 8 indexed citations
10.
Puleston, Richard, Colin Brown, Bharat Patel, et al.. (2020). Recommendations for detection and rapid management of carbapenemase-producing Enterobacterales outbreaks. Infection Prevention in Practice. 2(3). 100086–100086. 2 indexed citations
11.
Bell, Kirstine J., et al.. (2020). A position statement on screening and management of prediabetes in adults in primary care in Australia. Diabetes Research and Clinical Practice. 164. 108188–108188. 32 indexed citations
12.
Rodríguez, Allan, Andrew J. Wawrzyniak, Hansel Tookes, et al.. (2019). Implementation of an Immediate HIV Treatment Initiation Program in a Public/Academic Medical Center in the U.S. South: The Miami Test and Treat Rapid Response Program. AIDS and Behavior. 23(S3). 287–295. 17 indexed citations
13.
Coope, Caroline, Dean Ironmonger, Paul Cleary, et al.. (2019). An evaluation of the electronic reporting system for the enhanced surveillance of carbapenemase-producing Gram-negative bacteria in England. Journal of Hospital Infection. 102(1). 17–24. 1 indexed citations
14.
Pouwels, Koen B., Rachel Freeman, Berit Müller‐Pebody, et al.. (2018). Association between use of different antibiotics and trimethoprim resistance: going beyond the obvious crude association. Journal of Antimicrobial Chemotherapy. 73(6). 1700–1707. 52 indexed citations
15.
Freeman, Rachel, et al.. (2016). Interventions geared towards strengthening the health system of Namibia through the integration of palliative care. ecancermedicalscience. 10. 653–653. 5 indexed citations
16.
Freeman, Rachel, Gavin Dabrera, Chris Lane, et al.. (2015). Association between use of proton pump inhibitors and non-typhoidal salmonellosis identified following investigation into an outbreak ofSalmonellaMikawasima in the UK, 2013. Epidemiology and Infection. 144(5). 968–975. 21 indexed citations
17.
Mook, Piers, Sanch Kanagarajah, Helen Maguire, et al.. (2015). Selection of population controls for aSalmonellacase-control study in the UK using a market research panel and web-survey provides time and resource savings. Epidemiology and Infection. 144(6). 1220–1230. 14 indexed citations
18.
Moore, Luke, Rachel Freeman, Mark Gilchrist, et al.. (2014). Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London. Journal of Antimicrobial Chemotherapy. 69(12). 3409–3422. 34 indexed citations
19.
Freeman, Rachel, Luke Moore, Leticia García-Álvarez, André Charlett, & Alison Holmes. (2013). Advances in electronic surveillance for healthcare-associated infections in the 21st Century: a systematic review. Journal of Hospital Infection. 84(2). 106–119. 81 indexed citations
20.
Freeman, Rachel, André Charlett, Susan Hopkins, et al.. (2013). Evaluation of a national microbiological surveillance system to inform automated outbreak detection. Journal of Infection. 67(5). 378–384. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026